Surgical Science Sweden AB (SUS) — Free Cash Flow Generation Index
Surgical Science Sweden AB (SUS) has a Free Cash Flow Generation Index of 0.91x as of December 2025. Free cash flow of Skr66.65 Million represents 1% of operating cash flow (Skr72.89 Million). See Surgical Science Sweden AB (SUS) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Surgical Science Sweden AB Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Surgical Science Sweden AB across 11 annual periods. Explore Surgical Science Sweden AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Surgical Science Sweden AB (2015–2025)
Year-by-year Free Cash Flow Generation Index for Surgical Science Sweden AB. For the full company profile including market capitalisation, see SUS market cap overview.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.85x | Skr68.12 Million | Skr79.80 Million | Skr11.68 Million | ▲ +30.6% |
| 2024 | 0.65x | Skr89.69 Million | Skr137.22 Million | Skr47.53 Million | ▼ -19.8% |
| 2023 | 0.81x | Skr194.16 Million | Skr238.29 Million | Skr44.13 Million | ▲ +11.1% |
| 2022 | 0.73x | Skr94.94 Million | Skr129.49 Million | Skr34.55 Million | ▲ +16.0% |
| 2021 | 0.63x | Skr24.71 Million | Skr39.08 Million | Skr14.38 Million | ▲ +1.0% |
| 2020 | 0.63x | Skr14.53 Million | Skr23.23 Million | Skr8.69 Million | ▼ -25.4% |
| 2019 | 0.84x | Skr46.29 Million | Skr55.20 Million | Skr8.91 Million | ▲ +427.9% |
| 2018 | -0.26x | Skr-1.76 Million | Skr6.88 Million | Skr8.64 Million | ▲ +51.4% |
| 2017 | -0.53x | Skr-4.18 Million | Skr7.94 Million | Skr12.12 Million | ▼ -515.0% |
| 2016 | 0.13x | Skr1.70 Million | Skr13.40 Million | Skr11.70 Million | ▲ +218.9% |
| 2015 | -0.11x | Skr-800.00K | Skr7.50 Million | Skr8.30 Million | — |